Skip to Content

Join the 'Varicella-Zoster - Prophylaxis' group to help and get support from people like you.

Varicella-Zoster - Prophylaxis News

Health Tip: Identifying Chicken Pox

Posted 22 Sep 2017 by Drugs.com

-- While chicken pox is not as common as it used to be, youngsters and unvaccinated adults are still at risk. The highly contagious disease is caused by the varicella zoster virus. The American Academy of Pediatrics recommends that the first dose of the chicken pox vaccine be given at 12-15 months of age, and a second dose at 4-6 years of age. The academy says typical symptoms of chickenpox include: Itchy, blistery rash that appears 10 to 21 days after exposure to the virus. Blisters commonly emerge on the torso and scalp, then often spread to the face, arms and legs. Mild fever. Read more

Related support groups: Varicella-Zoster, Varicella Virus Vaccine, Measles Virus Vaccine/Mumps Virus Vaccine/Rubella Virus Vaccine/Varicella Virus Vaccine, ProQuad, Vaccination and Prophlaxis, Varivax, Varicella-Zoster - Prophylaxis

Health Tip: One of Three Adults Gets Shingles

Posted 8 Aug 2017 by Drugs.com

-- Adults 60 and older should be vaccinated for shingles, a very painful rash that's triggered by the same virus that causes chickenpox, the U.S. Centers for Disease Control and Prevention says. If you had chickenpox when you were younger, the vacicella-zoster virus may be lying inactive inside you and could trigger a nasty case of shingles. Symptoms of shingles include a blistery rash, itching, fatigue and fever. The best way to prevent shingles is to be vaccinated, the CDC says. People who have had shingles compare the pain to childbirth or having a kidney stone. Talk to your doctor about getting vaccinated. If you have the contagious disease, let others know about it, especially if someone you come in contact with has a compromised immune system. Read more

Related support groups: Varicella-Zoster, Vaccination and Prophlaxis, Varizig, Varicella-Zoster - Prophylaxis, Varicella Zoster Immune Globulin

Is Shingles Tied to Heart, Stroke Risk?

Posted 4 Jul 2017 by Drugs.com

TUESDAY, July 4, 2017 – Shingles may be tied to an increased risk for heart disease, a new study suggests. About one-third of Americans will develop shingles in their lifetime. The painful skin rash can occur in anyone who's had chickenpox, and the risk increases with age. The new study looked at 2003-2013 medical records for more than 23,000 people in South Korea who had shingles. The researchers also reviewed data on a similar number of people without shingles. They found the shingles group had a 59 percent higher risk of heart attack and a 35 percent higher risk of stroke than the others. Stroke risk was highest among those under 40. The risks of both stroke and heart attack were highest the first year after the onset of shingles and decreased with time, according to the study. The results appear in a research letter published July 3 in the Journal of the American College of ... Read more

Related support groups: Heart Disease, Ischemic Stroke, Herpes Zoster, Prevention of Cardiovascular Disease, Ischemic Stroke - Prophylaxis, Cardiovascular Risk Reduction, Thromboembolic Stroke Prophylaxis, Varicella-Zoster, Varicella Virus Vaccine, Ischemic Heart Disease, Measles Virus Vaccine/Mumps Virus Vaccine/Rubella Virus Vaccine/Varicella Virus Vaccine, ProQuad, Varicella-Zoster - Prophylaxis, Varivax

Zika-Bearing Mosquitoes More Widespread in U.S. Than Expected

Posted 20 Jun 2017 by Drugs.com

TUESDAY, June 20, 2017 – The latest buzz from federal health officials is that mosquitoes that can spread Zika, dengue and chikungunya viruses are in more counties in the southern United States than previously thought. After a Zika outbreak in Florida last summer, researchers from the U.S. Centers for Disease Control and Prevention expanded mosquito-collection measures across the South. The new study revealed a 21 percent increase in the number of counties with Zika-carrying mosquitoes (Aedes aegypti). There was also a 10 percent increase in counties with dengue-spreading mosquitoes (Aedes albopictus). The results don't mean these mosquitoes are abundant or madly transmitting the viruses. But the "findings highlight the need for continued and improved mosquito surveillance," wrote the team led by Micah Hahn. Hahn is with the CDC's division of vector-borne diseases in Fort Collins, ... Read more

Related support groups: Varicella-Zoster, Insect Bites, Zika Virus Infection, Varicella-Zoster - Prophylaxis, Dengue Fever

Shingles Vaccine Cuts Chronic Pain, Hospitalizations

Posted 17 Mar 2017 by Drugs.com

FRIDAY, March 17, 2017 – Vaccination greatly reduces the risk of serious complications from shingles, a new study finds. Shingles occurs when the same virus that causes chickenpox is reactivated later in life. Nearly one-third of people in the United States will develop shingles. The risk increases with age, researchers said. The new study showed the vaccine was 74 percent effective in preventing hospitalizations for shingles during the three years after vaccination. That number dropped to 55 percent effective after four or more years. The immunization was 57 percent effective for preventing lasting pain in the three years after vaccination. The rate dropped to 45 percent after four years, the researchers said. The findings were published recently in the journal Clinical Infectious Diseases. "The fact that we found relatively high effectiveness against serious outcomes, such as ... Read more

Related support groups: Herpes Zoster, Trigeminal Neuralgia, Zostavax, Varicella-Zoster, Zoster Vaccine Live, Vaccination and Prophlaxis, Herpes Zoster Peripheral Neuropathy, Varicella-Zoster - Prophylaxis

Experimental Shingles Vaccine Looks Quite Effective: Study

Posted 15 Sep 2016 by Drugs.com

WEDNESDAY, Sept. 14, 2016 – An experimental vaccine against shingles may offer lasting protection for most older adults who receive it, a new clinical trial found. Shingles is a painful rash that's triggered by a reactivation of the virus that causes chickenpox. About one-third of Americans develop the disease at some point, according to the U.S. Centers for Disease Control and Prevention (CDC). There already is a vaccine against shingles, but its effectiveness is limited. The new study found that the experimental vaccine protected about 90 percent of adults age 70 and up. And the effects were still apparent four years later. By comparison, the existing vaccine, Zostavax, cuts the risk of shingles by about half. And immunity wanes within five years, according to the CDC. The study results were published in the Sept. 15 issue of the New England Journal of Medicine. Researchers called ... Read more

Related support groups: Herpes Zoster, Zostavax, Varicella-Zoster, Herpes Zoster - Prophylaxis, Zoster Vaccine Live, Vaccination and Prophlaxis, Varicella-Zoster - Prophylaxis

Chickenpox Cases Down 85 Percent Since 2-Dose Vaccine Started: CDC

Posted 1 Sep 2016 by Drugs.com

THURSDAY, Sept. 1, 2016 – Chickenpox – which is caused by the varicella-zoster virus – has continued declining in the United States since 2006, when doctors began routinely recommending a second dose of chickenpox (varicella) vaccine, U.S. health officials said Thursday. States reporting vaccination data noted an 85 percent drop in the highly contagious disease between 2005-2006 and 2013-2014, according to a report from the U.S. Centers for Disease Control and Prevention. The fall-off was greatest among kids aged 5 to 14, health officials said. This is also the age group most likely to have received the second dose of varicella vaccine. Symptoms of chickenpox include an itchy, blistery rash, tiredness and fever. It tends to be more serious in babies, adults and people with a weakened immune system, the CDC noted. Before vaccination, chickenpox was commonplace, with 4 million ... Read more

Related support groups: Varicella-Zoster, Varicella Virus Vaccine, Measles Virus Vaccine/Mumps Virus Vaccine/Rubella Virus Vaccine/Varicella Virus Vaccine, ProQuad, Vaccination and Prophlaxis, Varicella Zoster Immune Globulin, Varizig, Varivax, Varicella-Zoster - Prophylaxis

Experimental Drug for Rheumatoid Arthritis Shows Promise

Posted 31 Mar 2016 by Drugs.com

THURSDAY, March 31, 2016 – An experimental drug to treat rheumatoid arthritis showed promise in a new six-month trial. Baricitinib substantially reduced symptoms and improved daily physical functioning among people who failed other treatments for the autoimmune disease, researchers found. "If you have active disease and you've failed existing treatment options, you should have hope," said lead researcher Dr. Mark Genovese. He is a professor of immunology and rheumatology at Stanford University School of Medicine in California. "There is another therapy, which will hopefully become available, that has demonstrated it can work in that situation." The report was published March 31 in the New England Journal of Medicine. The trial was sponsored by Eli Lilly and Co., the manufacturer of baricitinib. Lilly is currently seeking approval of the drug from the U.S. Food and Drug Administration. ... Read more

Related support groups: Rheumatoid Arthritis, High Cholesterol, Varicella-Zoster, Varicella-Zoster - Prophylaxis

Two-Dose Chickenpox Shot Gets the Job Done, Study Shows

Posted 14 Mar 2016 by Drugs.com

MONDAY, March 14, 2016 – Among school children, two doses of the chickenpox vaccine is better than one, a new study finds. Giving the first dose at age 1 and the second dose at ages 4 to 6 is nearly 100 percent effective in preventing the once common childhood disease, researchers have found. "A second dose of varicella [chickenpox] vaccine provides school-aged children with better protection against the chickenpox virus, compared to one dose alone or no vaccination," said lead researcher Dana Perella, of the Philadelphia Department of Public Health. Two doses of the vaccine protected against the moderate to severe chickenpox infections that can lead to complications and hospitalizations, she said. The report was published online March 14 and will appear in the April print issue of the journal Pediatrics. Chickenpox is a viral infection that causes a painful, itchy rash with small, ... Read more

Related support groups: Varicella-Zoster, Varicella Virus Vaccine, Measles Virus Vaccine/Mumps Virus Vaccine/Rubella Virus Vaccine/Varicella Virus Vaccine, ProQuad, Vaccination and Prophlaxis, Varivax, Varicella-Zoster - Prophylaxis

Health Tip: Chickenpox Can Be Dangerous

Posted 5 Feb 2016 by Drugs.com

-- Chickenpox is notoriously contagious, and for some people it can be very dangerous. Women who are pregnant, young children, the elderly and people with a weakened immune system are at greatest risk of complications. The U.S. Centers for Disease Control and Prevention mentions these potential complications of chickenpox: Pneumonia, blood poisoning or dehydration. Brain inflammation or infection. Bacterial infection affecting the skin or soft tissues, especially among children. Infection of the joints or bones. Toxic shock syndrome. Unusual bleeding. Read more

Related support groups: Varicella-Zoster, Varicella Virus Vaccine, Measles Virus Vaccine/Mumps Virus Vaccine/Rubella Virus Vaccine/Varicella Virus Vaccine, ProQuad, Vaccination and Prophlaxis, Varivax, Varicella-Zoster - Prophylaxis

Chickenpox, Shingles Vaccines Linked to Rare Eye Inflammation

Posted 25 Jan 2016 by Drugs.com

MONDAY, Jan. 25, 2016 – The vaccine for chickenpox and shingles has been linked to inflammation of the eye's cornea, but the number of such cases is small, a new study says. "Keratitis, or inflammation of the clear layer on the front of the eye, is a vision issue that can cause serious complications or even permanent damage to your vision if left untreated," Dr. Frederick Fraunfelder, chair of the ophthalmology department and director of the University of Missouri Eye Institute, said in a university news release. Researchers found 20 cases of keratitis in children and adults that occurred within a month of receiving a chickenpox or shingles vaccine. Symptoms of the disorder developed within 24 days of vaccination among adults. In children, symptoms began within 14 days of vaccination, the researchers said. The researchers said there is a probable relationship between the vaccine and ... Read more

Related support groups: Eye Conditions, Herpes Zoster, Zostavax, Varicella-Zoster, Keratitis, Corneal Ulcer, Eye Redness/Itching, Varicella Virus Vaccine, Corneal Abrasion, Herpes Zoster Iridocyclitis, Measles Virus Vaccine/Mumps Virus Vaccine/Rubella Virus Vaccine/Varicella Virus Vaccine, Visual Defect/Disturbance, ProQuad, Vaccination and Prophlaxis, Zoster Vaccine Live, Varicella-Zoster - Prophylaxis, Varivax

Health Tip: Coping With Chickenpox

Posted 24 Aug 2015 by Drugs.com

-- What can you do if you get chickenpox – besides scratch? The American Academy of Family Physicians suggests: Keep the room cool, as heat can make itchy skin worse. Put a cool, damp compress on the itchiest spots. Keep fingernails trimmed short so you don't break the skin if you do scratch. Soak in a lukewarm oatmeal bath. Apply calamine lotion. Read more

Related support groups: Skin Rash, Benadryl, Promethazine, Hydroxyzine, Zyrtec, Claritin, Diphenhydramine, Vistaril, Phenergan, Loratadine, Allegra, Cetirizine, Atarax, Cyproheptadine, Xyzal, Fexofenadine, Periactin, Chlorpheniramine, Levocetirizine, Benadryl Allergy

Vaccine Sharply Curbs Chickenpox Cases in U.S.

Posted 13 Aug 2015 by Drugs.com

THURSDAY, Aug. 13, 2015 – Chickenpox cases in the United States have dropped sharply since a vaccine against the disease became available in 1995, a new study shows. Also, hospitalizations and outpatient visits for chickenpox have continued to fall since 2006, when a second dose of the vaccine was recommended to boost protection against the disease, the researchers found. Before 1995, about 4 million people in the United States got chickenpox each year, nearly 11,000 were hospitalized, and up to 150 died of the disease, according to the U.S. Centers for Disease Control and Prevention. For this study, CDC researchers analyzed national health insurance claims data. They found there were 93 percent fewer hospitalizations for chickenpox in 2012, and 84 percent fewer outpatient visits for the disease than in the period before the vaccine was introduced. After the second dose recommendation ... Read more

Related support groups: Varicella-Zoster, Vaccination and Prophlaxis, Varicella-Zoster - Prophylaxis

Shingles Vaccine Appears to Cut Odds of Long-Term Pain

Posted 4 Jun 2015 by Drugs.com

TBD, 2015 – Even when shingles vaccination does not prevent the disease, it reduces the risk of long-term pain that can occur as a complication of the condition, according to a new study. Although the U.S. Advisory Council on Immunization Practices recommends shingles vaccination for people 60 and older, vaccination rates remain low, the researchers say. "Hopefully, this study will encourage more people to get vaccinated in order to reduce the long-term pain and potential disability associated with shingles," said lead author Hung Fu Tseng, a researcher with Kaiser Permanente Southern California. Tseng's team analyzed the medical records of 2,400 people in Southern California over age 60 who developed shingles. Some had been vaccinated against the disease. Among vaccinated patients, just over 4 percent of women and 6 percent of men developed long-term pain (post-herpetic neuralgia, or ... Read more

Related support groups: Persisting Pain, Shingles, Postherpetic Neuralgia, Varicella-Zoster, Varicella Virus Vaccine, Measles Virus Vaccine/Mumps Virus Vaccine/Rubella Virus Vaccine/Varicella Virus Vaccine, ProQuad, Varivax, Varicella-Zoster - Prophylaxis

Anti-Vaccine Parents Cluster in Rich, White Areas

Posted 3 Jun 2015 by Drugs.com

WEDNESDAY, June 3, 2015 – Parents who cite "personal beliefs" to get their children exempted from routine vaccinations are typically white and well-to-do – at least in California, a new study finds. The results, published June 1 in Pediatrics, confirm what other studies have suggested: Anti-vaccine sentiment in the United States appears strongest among wealthier white families. But the study also found another pattern that surprised experts: California schools with high rates of personal-belief exemptions often had high rates of exemptions for medical reasons, too. "There's no clear explanation for why that would be," said Dr. Paul Offit, chief of infectious diseases at Children's Hospital of Philadelphia, who was not involved in the study. But the concern, he added, is that some children exempted for medical reasons could be put at risk if their classmates are not vaccinated against ... Read more

Related support groups: BCG, Yellow Fever Vaccine, Prevnar 13, Zostavax, Gardasil, Prevnar, Measles, Vivotif Berna, Tetanus Toxoid, Typhoid Vaccine, Live, Hepatitis B Adult Vaccine, Rabies Vaccine, Human Diploid Cell, Varicella Virus Vaccine, Pneumococcal 23-polyvalent Vaccine, Vivotif Berna Vaccine, Pneumovax 23, Twinrix, Human Papillomavirus Vaccine, Rubella Virus Vaccine, Provenge

Page 1 2 3 Next

Ask a Question

Further Information

Related Condition Support Groups

Varicella-Zoster

Related Drug Support Groups

varicella virus vaccine, measles virus vaccine / mumps virus vaccine / rubella virus vaccine / varicella virus vaccine, ProQuad, Varivax